Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Debt-to-Equity : 0.01 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co Debt-to-Equity?

Wuhan Easy Diagnosis Biomedicine Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥11.2 Mil. Wuhan Easy Diagnosis Biomedicine Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥17.8 Mil. Wuhan Easy Diagnosis Biomedicine Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥6,045.5 Mil. Wuhan Easy Diagnosis Biomedicine Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity or its related term are showing as below:

SZSE:002932' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.02 Max: 0.18
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Wuhan Easy Diagnosis Biomedicine Co was 0.18. The lowest was 0.01. And the median was 0.02.

SZSE:002932's Debt-to-Equity is ranked better than
99.86% of 705 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SZSE:002932: 0.01

Wuhan Easy Diagnosis Biomedicine Co Debt-to-Equity Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co Debt-to-Equity Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.14

0.02

0.03

0.01

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.03	0.04	0.03	0.01	0.01

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity falls into.

Wuhan Easy Diagnosis Biomedicine Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Wuhan Easy Diagnosis Biomedicine Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(30.903	+	18.253)	/	6025.89
	=	0.01

Wuhan Easy Diagnosis Biomedicine Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.156	+	17.807)	/	6045.503
	=	0.00

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Wuhan Easy Diagnosis Biomedicine Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075

Website

http://www.mdeasydiagnosis.com

Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.

Executives

Wang Rui	Directors, executives
Wang Jian Fei	Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines